CY1650A - Ranitidine derivatives - Google Patents

Ranitidine derivatives

Info

Publication number
CY1650A
CY1650A CY1650A CY165092A CY1650A CY 1650 A CY1650 A CY 1650A CY 1650 A CY1650 A CY 1650A CY 165092 A CY165092 A CY 165092A CY 1650 A CY1650 A CY 1650A
Authority
CY
Cyprus
Prior art keywords
ranitidine
derivatives
ranitidine derivatives
Prior art date
Application number
CY1650A
Other languages
English (en)
Inventor
John Watson Clitherow
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888817098A external-priority patent/GB8817098D0/en
Priority claimed from GB898904686A external-priority patent/GB8904686D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of CY1650A publication Critical patent/CY1650A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
CY1650A 1988-07-18 1992-12-11 Ranitidine derivatives CY1650A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888817098A GB8817098D0 (en) 1988-07-18 1988-07-18 Chemical compounds
GB898904686A GB8904686D0 (en) 1989-03-01 1989-03-01 Chemical compounds

Publications (1)

Publication Number Publication Date
CY1650A true CY1650A (en) 1992-12-11

Family

ID=26294175

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1650A CY1650A (en) 1988-07-18 1992-12-11 Ranitidine derivatives

Country Status (35)

Country Link
US (1) US5008256A (de)
JP (1) JP2523185B2 (de)
KR (1) KR0122598B1 (de)
CN (1) CN1022626C (de)
AT (1) AT398200B (de)
AU (1) AU632052B2 (de)
BE (1) BE1003254A5 (de)
CA (1) CA1332610C (de)
CH (1) CH679582A5 (de)
CY (1) CY1650A (de)
DE (1) DE3923638C2 (de)
DK (1) DK168381B1 (de)
EG (1) EG19368A (de)
ES (1) ES2014175A6 (de)
FI (1) FI90538C (de)
FR (1) FR2634122B1 (de)
GB (1) GB2220937B (de)
GR (1) GR1000431B (de)
HK (1) HK61392A (de)
HU (2) HU206104B (de)
IE (1) IE61076B1 (de)
IL (1) IL91005A (de)
IT (1) IT1231481B (de)
LU (2) LU88722I2 (de)
MX (1) MX174145B (de)
MY (1) MY104055A (de)
NL (2) NL192604C (de)
NO (2) NO176319C (de)
NZ (1) NZ229958A (de)
PL (1) PL162391B1 (de)
PT (1) PT91188B (de)
SE (1) SE468715B (de)
SG (1) SG51992G (de)
YU (1) YU47021B (de)
ZW (1) ZW8689A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
EP0282132B1 (de) * 1987-03-09 1992-09-30 The Procter & Gamble Company Zusammensetzungen und ihre Verwendung zur Behandlung von Magen-Darmstörungen
AU641903B2 (en) * 1988-10-26 1993-10-07 Glaxo Group Limited Carboxylic acid derivatives
GB9004328D0 (en) * 1990-02-27 1990-04-25 Glaxo Group Ltd Chemical compounds
GB9009240D0 (en) * 1990-04-25 1990-06-20 Glaxo Group Ltd Chemical compounds
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds
IE65964B1 (en) * 1990-07-20 1996-01-24 Slagel David Products and processes for the treatment of the alimentary canal
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
DE69228738D1 (de) * 1991-12-06 1999-04-29 Glaxo Group Ltd Zusammensetzungen zur Behandlung von entzündlichen Zuständen oder Analgesie, die Ranitidin Wismuth Citrat und einen NSAID enthalten
WO1996019232A1 (en) * 1994-12-19 1996-06-27 Lauteral Limited Combinations of ranitidine hydrochloride-form 1 and bismuth compounds
US6117412A (en) * 1995-01-26 2000-09-12 Nycomed Imaging As Non-cluster type bismuth compounds
GB9501560D0 (en) * 1995-01-26 1995-03-15 Nycomed Imaging As Contrast agents
EP1035192A1 (de) * 1999-01-26 2000-09-13 Stefan Graichen Additiv für einen Kühlschmierstoff
CN1102585C (zh) * 1999-04-28 2003-03-05 常州兰陵制药有限公司 雷尼替丁枸橼酸铋盐的制备方法
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
CN100402514C (zh) * 2006-08-01 2008-07-16 丽珠医药集团股份有限公司 一种制备枸橼酸铋雷尼替丁的方法
WO2009008895A1 (en) * 2007-07-09 2009-01-15 Cypress Pharmaceutical, Inc. Pleasant-tasting ranitidine formulation
CN102408398B (zh) * 2011-09-20 2012-12-05 江苏汉斯通药业有限公司 枸橼酸铋雷尼替丁的制备方法
US9731999B2 (en) 2011-09-23 2017-08-15 Iqbal Gill Chemical admixtures for hydraulic cements
ES2426539B1 (es) * 2012-04-18 2014-09-09 Dr Healthcare España, S. L. Uso de la diaminooxidasa para el tratamiento o la prevención del trastorno por deficit de atencion con hiperactividad (adhd)
CN103896888B (zh) * 2014-03-28 2015-11-18 常州兰陵制药有限公司 枸橼酸铋雷尼替丁的制备方法
EP2929884A1 (de) 2014-04-11 2015-10-14 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmazeutische kombinationen aus dabigatran und h2-rezeptor-antagonisten
WO2015169957A1 (en) 2014-05-09 2015-11-12 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical combinations of rivaroxaban and h2-receptor antagonists
CN107382921A (zh) * 2017-07-28 2017-11-24 常州兰陵制药有限公司 制备枸橼酸铋雷尼替丁的方法
EP4196793A1 (de) 2020-08-11 2023-06-21 Université de Strasbourg Auf lebermakrophagen abzielende h2-blocker zur prävention und behandlung von lebererkrankungen und krebs

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
FR2531706A1 (fr) * 1982-08-13 1984-02-17 Sanofi Sa Benzamides, leurs sels, procede pour leur preparation et compositions pharmaceutiques les renfermant
BE905235A (fr) * 1986-08-05 1986-12-01 Hasunor Ag Ascorbates antagonistes des recepteurs h2 et leur procede de preparation.
IT1215325B (it) * 1987-01-07 1990-02-08 Barisintex Sa Composti antagonisti di recettori -h2 e procedimento per la loro preparazione.
EP0282132B1 (de) * 1987-03-09 1992-09-30 The Procter & Gamble Company Zusammensetzungen und ihre Verwendung zur Behandlung von Magen-Darmstörungen
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
DE3710462A1 (de) * 1987-03-30 1988-10-13 Heumann Pharma Gmbh & Co Pharmazeutische zubereitung zur behandlung von erkrankungen des magen-darm-traktes
GB9004328D0 (en) * 1990-02-27 1990-04-25 Glaxo Group Ltd Chemical compounds
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
BE1003254A5 (fr) 1992-02-11
YU142789A (en) 1991-04-30
FI893448A (fi) 1990-01-19
DK168381B1 (da) 1994-03-21
AU3817889A (en) 1990-01-18
PL162391B1 (pl) 1993-10-30
NO176319C (no) 1995-03-15
PT91188A (pt) 1990-02-08
LU87557A1 (fr) 1990-07-24
NO892936L (no) 1990-01-19
JPH02117684A (ja) 1990-05-02
GR1000431B (el) 1992-07-30
IE892309L (en) 1990-01-18
IL91005A (en) 1994-10-07
YU47021B (sh) 1994-11-15
LU88722I2 (fr) 1996-08-23
CN1039419A (zh) 1990-02-07
FI90538B (fi) 1993-11-15
DE3923638A1 (de) 1990-03-01
FR2634122B1 (fr) 1993-11-19
NL970046I1 (nl) 1998-03-02
DK351789A (da) 1990-01-19
ES2014175A6 (es) 1990-06-16
GB2220937B (en) 1991-11-27
SE8902550L (sv) 1990-01-19
FR2634122A1 (fr) 1990-01-19
NO176319B (no) 1994-12-05
MX16829A (es) 1993-10-01
HK61392A (en) 1992-08-21
NL8901840A (nl) 1990-02-16
NO892936D0 (no) 1989-07-17
EG19368A (en) 1995-02-28
GR890100454A (en) 1990-06-27
JP2523185B2 (ja) 1996-08-07
NL192604C (nl) 1997-11-04
IE61076B1 (en) 1994-09-21
ATA172889A (de) 1994-02-15
HU206104B (en) 1992-08-28
CH679582A5 (de) 1992-03-13
SE8902550D0 (sv) 1989-07-17
NZ229958A (en) 1991-09-25
ZW8689A1 (en) 1990-02-21
HUT52082A (en) 1990-06-28
GB2220937A (en) 1990-01-24
AT398200B (de) 1994-10-25
KR0122598B1 (ko) 1997-11-13
NO1998007I1 (no) 1998-02-05
SE468715B (sv) 1993-03-08
CN1022626C (zh) 1993-11-03
KR910002826A (ko) 1991-02-26
IT8948196A0 (it) 1989-07-17
AU632052B2 (en) 1992-12-17
NL192604B (nl) 1997-07-01
PT91188B (pt) 1995-03-01
NL970046I2 (nl) 1998-04-01
SG51992G (en) 1992-07-24
GB8916288D0 (en) 1989-08-31
CA1332610C (en) 1994-10-18
DK351789D0 (da) 1989-07-17
DE3923638C2 (de) 1995-11-23
FI90538C (fi) 1994-02-25
FI893448A0 (fi) 1989-07-17
MX174145B (es) 1994-04-25
US5008256A (en) 1991-04-16
IL91005A0 (en) 1990-02-09
HU211173A9 (en) 1995-11-28
MY104055A (en) 1993-10-30
IT1231481B (it) 1991-12-07

Similar Documents

Publication Publication Date Title
GB2220937B (en) Ranitidine derivatives
YU222289A (en) Hinuklidin derivatives
ZW7889A1 (en) Ranitidine
GB8905443D0 (en) Dihalogrnobenzene derivatives
GB2222828B (en) Butynylamine derivatives
PH27571A (en) Capsiacin derivatives
EG19385A (en) N-phenylpyrazol -4-yl-ether derivatives
GB8901863D0 (en) Acylphenol derivatives
ZA89860B (en) Pyranobenzoxadiazole derivatives
PH27235A (en) Benzopyranol derivatives
ZA892723B (en) Phosphonoalkylpurine derivatives
GB2222829B (en) Benzylidenecyclanone derivatives
YU200589A (en) Derivatives 3-acyl-2-oxyndol-1-carboxamida
PH27275A (en) Cycloalkylthiazole derivatives
ZA898604B (en) Pyranylethyl-naphthalene derivatives
IL90695A0 (en) Substituted azacyclohexyl derivatives
ZA893169B (en) 3-cyano-4-phenyl-pyrrole derivatives
ZA899582B (en) Benzohydroxymic derivatives
ZA895418B (en) Furan derivatives
IE880935L (en) Furan derivatives
FI103406B1 (fi) 3-piperatsinyylibentsatsolijohdannainen
GB8815823D0 (en) Cardanolactam derivatives
IL105594A0 (en) 3-piperazinyl-benzpyrazole derivatives
IE883569L (en) Cycloocteneimine derivatives
IE883320L (en) Acyllabdane derivatives